Livanova USA Inc.

Livanova USA Inc., a Houston-based manufacturer of medical devices, sells neurostimulation generators, cardiac perfusion equipment, surgical implants, and related maintenance services to federal healthcare agencies as a prime contractor competing on an unrestricted full-and-open basis with no set-aside designations. The company operates as a for-profit corporation and a large business entity, with 899 prime federal awards totaling $60.7 million in combined potential value across 29 distinct customer agencies over the past several years.

Livanova's capability portfolio centers on implantable neurological, cardiovascular, and surgical treatment devices. Representative work includes a $6.5 million blanket purchase agreement with the Defense Health Agency (established July 2021, ultimately completing July 2023) for vagus nerve stimulation therapy systems and related equipment to support epilepsy treatment at military healthcare facilities; a $497.6 thousand equipment maintenance and repair contract from Veterans Integrated Service Network 2 (awarded June 2024, completing May 2029) for heart-lung perfusion and surgical equipment; and a $468.3 thousand equipment maintenance contract from VISN 8 (awarded February 2026, completing February 2031) covering cardiovascular surgery and perfusion equipment. Livanova also holds a $6.5 million single-award BPA with the Defense Health Agency that has generated four firm fixed-price calls totaling $663.1 thousand to date for vagus nerve stimulation generators and associated equipment delivered through May 2023.

Customer concentration is heavily skewed toward the Defense Health Agency and military medical treatment facilities. The Defense Health Agency ranks first by potential value at $19.4 million across 73 awards, while the Department of the Army Medical Command follows with $8.1 million across 87 awards, and the Department of the Navy Bureau of Medicine and Surgery places third with $4.9 million across 171 awards. These three defense customers account for 61% of combined potential value. The top five customer agencies by award count (Navy, Army, Defense Health Agency, VISN 6, and VISN 10) represent 49% of all awards. The Defense Health Agency's dominance by dollar value reflects both the size of individual orders and the strategic importance of neurological and cardiac treatment technologies to military healthcare operations.

Livanova's vehicle position centers on the Defense Health Agency BPA HT001421A0015 ($6.5 million ceiling, single award), which has yielded four task orders totaling $483 thousand. The vendor also places work under an Indefinite Delivery Contract W81K0007A0016 (23 task orders, $438 thousand combined value) and BPA HT001416A0073 (11 task orders, $2.1 million combined value). These vehicles facilitate recurring procurement of medical devices and maintenance services across military treatment facilities and VA medical centers.

Activity has remained relatively stable year over year, with 30 awards in 2022, 33 in 2023, 38 in 2024, 19 in 2025, and 13 in 2026 through early August. Nine awards (combined potential value $803 thousand) reach ultimate completion within the next twenty-four months, presenting moderate recompete exposure. The vendor's longest-running maintenance contracts extend through 2030 and 2031, anchoring stable, recurring revenue in cardiovascular perfusion and equipment support services.

Livanova's product category concentration reflects its position as a specialized medical device manufacturer. Electromedical and Electrotherapeutic Apparatus Manufacturing (NAICS 334510) covers 343 awards; Surgical Appliance and Supplies Manufacturing (NAICS 339113) covers 257 awards; and Surgical and Medical Instrument Manufacturing (NAICS 339112) covers 175 awards. The Medical and Surgical Instruments, Equipment, and Supplies PSC dominates the award portfolio with 826 awards, with maintenance and repair services (PSC J065) accounting for 53 additional awards. Livanova competes across its entire portfolio without set-asides, positioning itself as a large business vendor for federal healthcare agencies.